0001144204-18-065469.txt : 20181219 0001144204-18-065469.hdr.sgml : 20181219 20181219190025 ACCESSION NUMBER: 0001144204-18-065469 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181217 FILED AS OF DATE: 20181219 DATE AS OF CHANGE: 20181219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shapiro David CENTRAL INDEX KEY: 0001559570 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35668 FILM NUMBER: 181244406 MAIL ADDRESS: STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC. STREET 2: 18 DESBROSSES ST. CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001270073 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223868459 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 HUDSON YARDS, 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 646-747-1000 MAIL ADDRESS: STREET 1: 10 HUDSON YARDS, 37TH FLOOR CITY: New York STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC DATE OF NAME CHANGE: 20031113 4 1 tv509353_4.xml OWNERSHIP DOCUMENT X0306 4 2018-12-17 0 0001270073 INTERCEPT PHARMACEUTICALS, INC. ICPT 0001559570 Shapiro David C/O INTERCEPT PHARMACEUTICALS, INC. 10 HUDSON YARDS, FLOOR 37 NEW YORK NY 10001 0 1 0 0 Chief Medical Officer Common Stock 2018-12-17 4 M 0 2000 31.90 A 41152 D Common Stock 2018-12-17 4 S 0 2000 106.62 D 39152 D Option to Purchase Common Stock 31.90 2018-12-17 4 M 0 2000 0 D 2023-05-07 Common Stock 2000 19031 D This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person. This option is fully vested and exercisable. /s/ Mark Pruzanski, as attorney-in-fact 2018-12-19